New Strategic Research and Innovation Agenda on Antimicrobial Resistance

The updated Strategic Research and Innovation Agenda (SRIA) from the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) presents an overview of recent developments and future needs for AMR research. The SRIA outlines six key priority topics within the AMR field: Therapeutics, Diagnostics, Surveillance Transmission, Environment and Interventions, and has defined a set of research objectives within each priority topic. Together, 27 countries has created the SRIA.

The SRIA highlights many important research needs, some of which include:

  • The need to address AMR with a holistic One Health approach.
  • The necessity of including innovation in every aspect of AMR research.
  • Increased inclusion of low- and middle income countries (LMIC´s)
  • The need for developments incorporating personalised medicine and artificial intelligence, and more.

The SRIA is a prime guiding tool for AMR research prioritisation in investments, research activities and planning for JPIAMR member states and other funding initiatives.

Read the SRIA on JPIAMR:s website External link..

The Swedish Research Council hosts the JPIAMR Secretariat in Stockholm, Sweden.



Pdf / Printout


  1. Towards a One Health AMR partnership

    On 3 February, JPIAMR organises an international conference to discuss and shape a new partnership with a so-called "One Health" perspective. The conference is aimed at the research community, research policy actors as well as the public and private ...

  2. "Research is key in the work against antibiotic resistance"

    To safeguard the world’s supply of effective medicines, we need large resources for research and innovation, broad-based global collaboration and clear leadership. Sweden plays a leading role in the international efforts against antibiotic resistance...

  3. The importance of the environment in spreading antibiotic resistance is underestimated

    We tend to underestimate the role played by the environment when it comes to spreading antibiotic resistance. Limiting resistance in poor countries is central for limiting future problems in other countries too. This is the view of Joakim Larsson, wh...